50-840-80001

MilliporeSigma™ Calbiochem™ InSolution™ Batimastat

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 50-840-80001-Each-of-1 In Stock ₹ 12,341.17

50-840-80001 - Each of 1

₹ 12,341.17

In Stock

Quantity

1

Base Price: ₹ 12,341.17

GST (18%): ₹ 2,221.411

Total Price: ₹ 14,562.581

Formulation

A 25 mM (2mg/168μL) sterile-filtered solution of Batimastat in DMSO.

Target Proteins

MMPs

Formula Weight

477.6g/mol

Form

Liquid

Description

97% by HPLC

Molecular Formula

C23H31N3O4S2

Content And Storage

Avoid Freeze-Thaw Cycles, Hygroscopic, Protect from Light

Quantity

2 mg

Related Products

Img

MilliporeSigma™

50-522-40001

--

Img

MilliporeSigma™

50-873-80001

--

Img

MilliporeSigma™

50-833-60001

--

Img

MilliporeSigma™

50-819-70001

--

Img

MilliporeSigma™

50-834-00001

--

Img

MilliporeSigma™

50-822-70001

--

Img

MilliporeSigma™

50-831-40001

--

Img

MilliporeSigma™

50-608-10001

--

Description

  • A Marimastat (Cat
  • No
  • 444289) type of peptidyl hydroxamate-based inhibitor that potently inhibits a broad-spectrum of metalloproteinases, including MMP-1, MMP-2, MMP-3/stromelysin, MMP-7/matrilysin, MMP-9, δMT1 (MMP-14 without TM domain), ADAM8, and ADAM17/TACE (IC 50 = 3, 4, 20, 6, 4, 2.08, 51.3, and 19 nM, respectively), by targeting both the substrate binding site and the active-site Zn 2+ , while being much less potent toward ACE (Angiotensin Converting Enzyme) or α-secretase (IC 50 = 1.6 and 3.3μM, respectively)
  • Batimastat is widely used in studying the involvement of MMPs in cancinogenesis and non-cancer pathological processes both in cultures in vitro and in animals in vivo .